<p>Baseline characteristics of the sickle cells disease population of this study.</p
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
Baseline characteristics of the total study population and the sample used for analysis.</p
<p>Baseline characteristics of the population of study: HIV-infection related characteristics.</p
<p>Clinical, demographic and laboratory baseline characteristics of the study population.</p
Demographic and clinical characteristics of the study population at baseline.</p
Baseline characteristics of the study population according to frailty status.</p
Baseline demographic data and clinical characteristics of the study population.</p
<p>Baseline characteristics of the study populations in the 22 studies included in this analysis.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
Baseline characteristics of the study population by the median of creatinine level.</p
<p>Baseline characteristics of HLA genotyping for the study participants stratified by district.</p
<p>Baseline characteristics according to study population and sensitization status.</p
<p>The baseline characteristics and laboratory results of the study populations.</p
<p>Baseline characteristics of study participants according to diagnostic groups.</p
<p>Baseline characteristics of the study population by tertile of FEV<sub>1</sub>.</p
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
Baseline characteristics of the total study population and the sample used for analysis.</p
<p>Baseline characteristics of the population of study: HIV-infection related characteristics.</p
<p>Clinical, demographic and laboratory baseline characteristics of the study population.</p
Demographic and clinical characteristics of the study population at baseline.</p
Baseline characteristics of the study population according to frailty status.</p
Baseline demographic data and clinical characteristics of the study population.</p
<p>Baseline characteristics of the study populations in the 22 studies included in this analysis.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
Baseline characteristics of the study population by the median of creatinine level.</p
<p>Baseline characteristics of HLA genotyping for the study participants stratified by district.</p
<p>Baseline characteristics according to study population and sensitization status.</p
<p>The baseline characteristics and laboratory results of the study populations.</p
<p>Baseline characteristics of study participants according to diagnostic groups.</p
<p>Baseline characteristics of the study population by tertile of FEV<sub>1</sub>.</p
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
Baseline characteristics of the total study population and the sample used for analysis.</p
<p>Baseline characteristics of the population of study: HIV-infection related characteristics.</p
DOI
Add to ORKG